Search

Through design and development work, Max Mobility has identified a software issue with the application. When multiple processes are running on the watch's central processing unit, the application may crash unexpectedly. If this happens, the motor on the…

During the transportation of the product (only one box) from McKesson Canada to the customer, the vehicle was involved in an accident thereby exposing the products to external freezing weather conditions as low as -16°c for approximately 2 days. Due to a…

Stryker has determined that the affected pad-paks may be rendered inoperable due to depleted battery cells. As a result, the affected pad-paks could potentially fail to power on the device if needed for use. Recall start date: May 3, 2023

The attachment pin and lock can wear down faster than expected in certain circumstances. Faster wear can result in the potential for the pin to disengage from the lock, leading to loss of suspension, potentially leading to an injury. Recall start date…

An impurity is out of specification in the affected lot.

The new software version VC20G provides latest cybersecurity updates and improvements in the following categories: - Improves overall system stability - Improves dicom connectivity - Improves biopsy workflow Specifically, the new software version…

The Anti-Factor Ila potency is out of specification in the affected lot.

Philips Respironics has detected environmental contamination (e.g. External dust and dirt) in the air path of some devices that have been returned from the field. Extended exposure to these environmental contaminants can lead to buildup of particulate on…

BD observed a nonconforming condition where some catheters manufactured had the clear resealing label separating from the product foil pouch, resulting in a possible path into the product packaging that could potentially result in a sterile barrier…

When the Defigard Touch-7 is configured to power on directly in manual defibrillation mode, the charge button may be inactive. Recall start date: January 2, 2023

Affected lot is missing risk statements on the outer label; Affected lot is labelled with claims that are not compliant with its terms of market authorization; Regulated party does not hold a site licence for sale of the product in Canada.

 Unauthorized health products for use in the pediatric subpopulation.

Product sold without market authorization (DIN) in Canada. Affected lot contains undeclared Dehydrolatanoprost, a prostaglandin analogue. Prostaglandin analogues are listed in the prescription drug list

Philips Respironics has detected environmental contamination (e.g. external dust and dirt) in the air path of some devices that have been returned from the field. Extended exposure to these environmental contaminants can lead to buildup of particulate on…

Steris has identified that in the remote occurrence in which the electrical contactor component present in the drying chambers of the reliance vision multi-chamber washer/disinfector malfunctions, the heating elements in the drying chamber could overheat…